AD: Promising Long-Term Safety Profile for Dupilumab in Real-World Data
Thrasyvoulos Tzellos presents in this MEDtalk the results from a multinational prospective long-term study that assessed both efficacy and safety for treatment with dupilumab in real-world practice. According to Thrasyvoulos Tzellos, the study’s results are very promising in terms of safety.
